Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
0.623
+0.013 (2.13%)
At close: Apr 28, 2026, 4:00 PM EDT
0.520
-0.103 (-16.53%)
After-hours: Apr 28, 2026, 7:54 PM EDT
Basel Medical Group Income Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| Operating Revenue | 11.32 | 10.05 | 9.7 | 10.66 |
| Other Revenue | 0.04 | - | 0.05 | - |
| Revenue | 11.35 | 10.05 | 9.75 | 10.66 |
| Revenue Growth (YoY) | 12.97% | 3.12% | -8.55% | - |
| Cost of Revenue | 8.95 | 5.89 | 5.58 | 2.72 |
| Gross Profit | 2.4 | 4.16 | 4.16 | 7.94 |
| Selling, General & Admin | 0.14 | 0 | 1.05 | 5.78 |
| Other Operating Expenses | 3.22 | 1.44 | 0.55 | -0.31 |
| Operating Expenses | 4.55 | 1.97 | 2.16 | 5.48 |
| Operating Income | -2.14 | 2.2 | 2 | 2.46 |
| Interest Expense | -0.2 | -0.18 | -0.24 | -0.32 |
| Interest & Investment Income | 0.08 | - | 0.3 | 0.25 |
| Other Non Operating Income (Expenses) | 1.56 | 0.39 | 0.07 | - |
| EBT Excluding Unusual Items | -0.7 | 2.4 | 2.13 | 2.39 |
| Impairment of Goodwill | -10.35 | - | - | - |
| Pretax Income | -11.05 | 2.4 | 2.13 | 2.39 |
| Income Tax Expense | -0.42 | 0.33 | 0.35 | 0.41 |
| Earnings From Continuing Operations | -10.64 | 2.07 | 1.78 | 1.98 |
| Minority Interest in Earnings | 0 | - | - | - |
| Net Income | -10.64 | 2.07 | 1.78 | 1.98 |
| Net Income to Common | -10.64 | 2.07 | 1.78 | 1.98 |
| Net Income Growth | - | 16.23% | -9.84% | - |
| Shares Outstanding (Basic) | 19 | 16 | 16 | 16 |
| Shares Outstanding (Diluted) | 19 | 16 | 16 | 16 |
| Shares Change (YoY) | 15.60% | - | - | - |
| EPS (Basic) | -0.57 | 0.13 | 0.11 | 0.12 |
| EPS (Diluted) | -0.57 | 0.13 | 0.11 | 0.12 |
| EPS Growth | - | 16.23% | -9.84% | - |
| Free Cash Flow | -14.94 | 2.5 | 2.59 | 2.7 |
| Free Cash Flow Per Share | -0.80 | 0.15 | 0.16 | 0.17 |
| Gross Margin | 21.18% | 41.43% | 42.71% | 74.48% |
| Operating Margin | -18.85% | 21.84% | 20.55% | 23.09% |
| Profit Margin | -93.67% | 20.62% | 18.30% | 18.56% |
| Free Cash Flow Margin | -131.58% | 24.89% | 26.61% | 25.37% |
| EBITDA | -2.03 | 2.23 | 2.03 | 2.48 |
| EBITDA Margin | -17.91% | 22.14% | 20.86% | 23.30% |
| D&A For EBITDA | 0.11 | 0.03 | 0.03 | 0.02 |
| EBIT | -2.14 | 2.2 | 2 | 2.46 |
| EBIT Margin | -18.85% | 21.84% | 20.55% | 23.09% |
| Effective Tax Rate | - | 13.80% | 16.34% | 17.12% |
Source: S&P Capital IQ. Standard template.
Financial Sources.